These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3127263)

  • 1. Use of immobilized enzymes in drug metabolism studies.
    Dulik DM; Fenselau C
    FASEB J; 1988 Apr; 2(7):2235-40. PubMed ID: 3127263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of inducers on drug-metabolizing enzyme activity and on formation of reactive drug metabolites in the liver.
    Orrenius S; Thor H; Jernström B
    Ciba Found Symp; 1980; 76():25-42. PubMed ID: 6109599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplicity of liver drug metabolizing enzymes.
    Lu AY
    Drug Metab Rev; 1979; 10(2):187-208. PubMed ID: 121803
    [No Abstract]   [Full Text] [Related]  

  • 4. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
    Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
    Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biological methods for characterizing drug-metabolizing enzymes in hepatic and extrahepatic tissues.
    Friedberg T
    Skin Pharmacol Appl Skin Physiol; 1998; 11(2):61-9. PubMed ID: 9603656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues.
    Albin N; Massaad L; Toussaint C; Mathieu MC; Morizet J; Parise O; Gouyette A; Chabot GG
    Cancer Res; 1993 Aug; 53(15):3541-6. PubMed ID: 8339260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of perfluorodecalin on activities of hepatic phase II xenobiotic biotransformation enzymes.
    Kalinina EV; Obraztsov VV; Shekhtman DG; Gudkova OV; Kukushkin NI; Saprin AN
    Biochem Int; 1991 Jun; 24(3):543-8. PubMed ID: 1772431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitamin A deficiency on hepatic and intestinal drug metabolizing enzymes in rats.
    Gupta PH; Mehta S; Mehta SK
    Biochem Int; 1989 Jul; 19(1):123-33. PubMed ID: 2505773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenobiotic-metabolizing enzymes in carp (Cyprinus carpio) liver, spleen, and head kidney following experimental Listeria monocytogenes infection.
    Chambras C; Marionnet D; Taysse L; Deschaux P; Moreau J; Bosgiraud C
    J Toxicol Environ Health A; 1999 Feb; 56(3):205-19. PubMed ID: 9973004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of monoxygenases in the metabolism of drugs in the human fetus and newborn infant].
    Cresteil T; Leroux JP
    Arch Fr Pediatr; 1982; 39(7):463-70. PubMed ID: 6816186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of metabolizing enzymes by bisphenol a in human and animal models.
    Quesnot N; Bucher S; Fromenty B; Robin MA
    Chem Res Toxicol; 2014 Sep; 27(9):1463-73. PubMed ID: 25142872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of drugs in human skin.
    Svensson CK
    Drug Metab Dispos; 2009 Feb; 37(2):247-53. PubMed ID: 19005027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human drug metabolizing enzymes. II. Conjugation enzymes].
    Vereczkey L; Jemnitz K; Gregus Z
    Acta Pharm Hung; 1998 Sep; 68(5):284-8. PubMed ID: 9805814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs.
    Urquhart BL; Tirona RG; Kim RB
    J Clin Pharmacol; 2007 May; 47(5):566-78. PubMed ID: 17442683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic Conversion of Lipophilic Substrates by Phase constrained Enzymes in the Aqueous or in the Membrane Phase.
    Cebula M; Turan IS; Sjödin B; Thulasingam M; Brock J; Chmyrov V; Widengren J; Abe H; Mannervik B; Haeggström JZ; Rinaldo-Matthis A; Akkaya EU; Morgenstern R
    Sci Rep; 2016 Dec; 6():38316. PubMed ID: 27917951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
    Serpe L; Canaparo R; Scordo MG; Spina E
    Drug Metab Pers Ther; 2015 Jun; 30(2):107-20. PubMed ID: 25527811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical properties of some microsomal xenobiotic-metabolizing enzymes in rabbit small intestine.
    Chhabra RS; Fouts JR
    Drug Metab Dispos; 1976; 4(3):208-14. PubMed ID: 6224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Metabolism of Sakuranetin and Its Modulating Effects on Cytochrome P450s and UDP-Glucuronosyltransferases.
    Jeong H; Lee J; Kim S; Yeo YY; So H; Wu H; Song YS; Jang CY; Kim HD; Kim MJ; Chang M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29949932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms.
    McCarver DG; Hines RN
    J Pharmacol Exp Ther; 2002 Feb; 300(2):361-6. PubMed ID: 11805192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous immobilization of cytochrome P-450 and glucuronyltransferase for synthesis of drug metabolites.
    Lehman JP; Ferrin L; Fenselau C; Yost GS
    Drug Metab Dispos; 1981; 9(1):15-8. PubMed ID: 6111425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.